Cited by 833Pharmaceutical Practices and Patient OutcomesTreatment of Major DepressionMental Health Treatment and Access

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Antidepressant use and risk of adverse outcomes in older people: population based cohort study

Open access

Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., Hippisley-Cox, J.·2011·BMJ

DOI 10.1136/bmj.d4551PMC PMC3149102

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: To investigate the association between antidepressant treatment and risk of several potential adverse outcomes in older people with depression and to examine risks by class of antidepressant, duration of use, and dose. DESIGN: Cohort study of people aged 65 and over diagnosed as having depression. SETTING: 570 general practices in the United Kingdom supplying data to the QResearch primary care database. PARTICIPANTS: 60,746 patients diagnosed as having a new episode of depression between the ages of 65 and 100 years from 1 January 1996 to 31 December 2007 and followed up until 31 December 2008. MAIN OUTCOME MEASURES: Hazard ratios associated with antidepressant use for all cause mortality, attempted suicide/self harm, myocardial infarction, stroke/transient ischaemic attack, falls, fractures, upper gastrointestinal bleeding, epilepsy/seizures, road traffic accidents, adverse drug reactions, and hyponatraemia, adjusted for a range of potential confounding variables. Hazard ratios were calculated for antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, and duration of use and for commonly prescribed individual drugs. RESULTS: 54,038 (89.0%) patients received at least one prescription for an antidepressant during follow-up. A total of 1,398,359 antidepressant prescriptions were issued: 764,659 (54.7%) for selective serotonin reuptake inhibitors, 442,192 (31.6%) for tricyclic antidepressants, 2203 (0.2%) for monoamine oxidase inhibitors, and 189,305 (13.5%) for the group of other antidepressants. The associations with the adverse outcomes differed significantly between the antidepressant classes for seven outcomes. Selective serotonin reuptake inhibitors were associated with the highest adjusted hazard ratios for falls (1.66, 95% confidence interval 1.58 to 1.73) and hyponatraemia (1.52, 1.33 to 1.75) compared with when antidepressants were not being used. The group of other antidepressants was associated with the highest adjusted hazard ratios for all cause mortality (1.66, 1.56 to 1.77), attempted suicide/self harm (5.16, 3.90 to 6.83), stroke/transient ischaemic attack (1.37, 1.22 to 1.55), fracture (1.64, 1.46 to 1.84), and epilepsy/seizures (2.24, 1.60 to 3.15), compared with when antidepressants were not being used. Tricyclic antidepressants did not have the highest hazard ratio for any of the outcomes. Significantly different associations also existed between the individual drugs for the same seven outcomes; trazodone (tricyclic antidepressant), mirtazapine, and venlafaxine (both in the group of other antidepressants) were associated with the highest rates for some of these outcomes. Absolute risks over 1 year for all cause mortality were 7.04% for patients while not taking antidepressants, 8.12% for those taking tricyclic antidepressants, 10.61% for selective serotonin reuptake inhibitors, and 11.43% for other antidepressants. CONCLUSIONS: Selective serotonin reuptake inhibitors and drugs in the group of other antidepressants were associated with an increased risk of several adverse outcomes compared with tricyclic antidepressants. Among individual drugs, trazodone, mirtazapine, and venlafaxine were associated with the highest risks for some outcomes. As this is an observational study, it is susceptible to confounding by indication, channelling bias, and residual confounding, so differences in characteristics between patients prescribed different antidepressant drugs that could account for some of the associations between the drugs and the adverse outcomes may remain. Further research is needed to confirm these findings, but the risks and benefits of different antidepressants should be carefully evaluated when these drugs are prescribed to older people.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.d4551

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

British National Formulary
(1958) · Journal of the American Pharmaceutical Association (Scientific ed ) · doi:10.1002/jps.3030470133 · Cited by 2,491
Health and Deprivation: Inequality and the North
Townsend, P. D., Phillimore, P., & Beattie, A. (1987) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1,473
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353
Review of community prevalence of depression in later life
Beekman, A. T. F., Copeland, J. R. M., & Prince, M. J. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.4.307 · Cited by 1,139
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Health and Deprivation: Inequality and the North
Blane, D., Townsend, P. D., Phillimore, P., & Beattie, A. (1989) · British Journal of Sociology · doi:10.2307/590279 · Cited by 756
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719
Calculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710
Validity of diagnostic coding within the General Practice Research Database: a systematic review
Khan, N., Harrison, S., & Rose, P. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483562 · Cited by 702
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609

Flagged first, then by citations

Show all 66 references

1 of the 66 references couldn’t be matched to a known paper.

Sorted by citations

Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Post-Stroke Depression: A Review
Robinson, R. G., & Jorge, R. E. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030363 · Cited by 1,152
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“, 2013) and that treatment should be based on symptom and side effect profile and the need to avoid interactions (Coupland et al., 2011).”
Background
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial
Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.93 · Cited by 572
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 551
Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics
Seppala, L. J., Wermelink, A. M. A. T., de Vries, M., Ploegmakers, K. J., van de Glind, E. M. M., Daams, J. G., van der Velde, N., Blain, H., Bousquet, J., Bucht, G., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.098 · Cited by 517
Low back pain in older adults: risk factors, management options and future directions
Wong, A. Y. L., Karppinen, J. I., & Samartzis, D. (2017) · Scoliosis and Spinal Disorders · doi:10.1186/s13013-017-0121-3 · Cited by 502
The advances of post-stroke depression: 2021 update
Guo, J., Wang, J., Sun, W., & Liu, X. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10597-4 · Cited by 434
Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study
Hippisley-Cox, J., & Coupland, C. (2012) · British medical journal · doi:10.1136/bmj.e3427 · Cited by 357
Self-citation
Medication-Related Falls in the Elderly
Huang, A. R., Mallet, L., Rochefort, C. M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. M. (2012) · Drugs & Aging · doi:10.2165/11599460-000000000-00000 · Cited by 365
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence
Bockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295
The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 282
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
MacQUEEN, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M. S., Lieshout, R. J. V., Kennedy, S. H., Lam, R. W. M., Milev, R. V., Parikh, S. V., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659276 · Cited by 266
Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
Rodrigues, M. C. S., & de Oliveira, C. M. (2016) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.1316.2800 · Cited by 241
Side effects of antidepressants during long-term use in a naturalistic setting
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239
Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: A systematic review and meta-analysis
Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.82 · Cited by 234
Exercise for depression in older adults: a meta-analysis of randomized controlled trials adjusting for publication bias
Schuch, F. B., Vancampfort, D., Rosenbaum, S., Richards, J., Ward, P. B., Veronese, N., Solmi, M., Cadore, E. L., & Stubbs, B. (2016) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2016-1915 · Cited by 226
Depressive Symptomatology as a Risk Factor for Falls in Older People: Systematic Review and Meta‐Analysis
Kvelde, T., McVeigh, C., Toson, B., Greenaway, M., Lord, S. R., Delbaere, K., & Close, J. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12209 · Cited by 214
Placebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
Antidepressant medications and osteoporosis
Rizzoli, R., Cooper, C. C., Reginster, J., Abrahamsen, B., Adachi, J. D., Brandi, M. L., Bruyère, O., Compston, J. E., Ducy, P. F., Ferrari, S., et al. (2012) · Bone · doi:10.1016/j.bone.2012.05.018 · Cited by 192
Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature
Picker, L. D., Eede, F. V. D., Dumont, G., Moorkens, G. H., & Sabbe, B. (2014) · Psychosomatics · doi:10.1016/j.psym.2014.01.010 · Cited by 186
Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs
Konrat, C., Boutron, I., Trinquart, L., Auleley, G.-R., Ricordeau, P., & Ravaud, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033559 · Cited by 164
The effectiveness of group reminiscence therapy for loneliness, anxiety and depression in older adults in long-term care: A systematic review
Elias, S. M. S., Neville, C. C., & Scott, T. (2015) · Geriatric Nursing · doi:10.1016/j.gerinurse.2015.05.004 · Cited by 163
Medications associated with falls in older people: systematic review of publications from a recent 5-year period
Park, H., Satoh, H., Miki, A., Urushihara, H., & Sawada, Y. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1955-3 · Cited by 158
Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database
Coupland, C. A. C., Hill, T., Morriss, R. K., Arthur, A. J., Moore, M. V., & Hippisley‐Cox, J. (2015) · BMJ · doi:10.1136/bmj.h517 · Cited by 162
Self-citation
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial
Hankey, G. J., Hackett, M. L., Almeida, O. P., Flicker, L. A., Mead, G. E., Dennis, M. S., Etherton‐Beer, C., Ford, A. H., Billot, L., Jan, S., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30207-6 · Cited by 149
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
Coupland, C. A. C., Dhiman, P., Barton, G., Morriss, R. K., Arthur, A. J., Sach, T., & Hippisley‐Cox, J. (2011) · Health Technology Assessment · doi:10.3310/hta15280 · Cited by 146
Self-citation
Depression in older adults
Wilkinson, P., Ruane, C., & Tempest, K. (2018) · BMJ · doi:10.1136/bmj.k4922 · Cited by 146
The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
Loddo, G., Buonaura, G. C., Sambati, L., Giannini, G., Cecere, A., Cortelli, P., & Provini, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00042 · Cited by 143
Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study
Noordam, R., Aarts, N., Verhamme, K. M. C., Sturkenboom, M., Stricker, B. H. C., & Visser, L. E. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1803-x · Cited by 134
Prevention of depression in older age
Almeida, O. P. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.03.005 · Cited by 132
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States
Palmsten, K. K., Hernández–Dı́az, S., Huybrechts, K. F., Williams, P. L., Michels, K. B., Achtyes, E. D., Mogun, H., & Setoguchi, S. (2013) · BMJ · doi:10.1136/bmj.f4877 · Cited by 131
Influence of seizures on stroke outcomes
Huang, C., Saposnik, G., Fang, J., Steven, D. A., & Burneo, J. G. (2014) · Neurology · doi:10.1212/wnl.0000000000000166 · Cited by 133
Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults
Johnell, K., Jonasdottir Bergman, G., Fastbom, J., Danielsson, B., Borg, N., & Salmi, P. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4483 · Cited by 130
Antidepressants for people with epilepsy and depression
Maguire, M., Weston, J., Singh, J. A., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010682.pub2 · Cited by 129
Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial
Bergh, S., Selbaek, G., & Engedal, K. (2012) · BMJ · doi:10.1136/bmj.e1566 · Cited by 124
Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database
Coupland, C. A. C., Hill, T., Morriss, R. K., Moore, M. V., Arthur, A. J., & Hippisley‐Cox, J. (2016) · BMJ · doi:10.1136/bmj.i1350 · Cited by 127
Self-citation
Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia
Deardorff, W. J., & Grossberg, G. T. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00002-2 · Cited by 133
Depressive Symptoms, Chronic Pain, and Falls in Older Community‐Dwelling Adults: The MOBILIZE Boston Study
Eggermont, L. H. P., Penninx, B. W. J. H., Jones, R. N., & Leveille, S. G. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03829.x · Cited by 123
Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review
van Poelgeest, E. P., Pronk, A. C., Rhebergen, D., & van der Velde, N. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00475-7 · Cited by 131
Antidepressants and the risk of hyponatremia: a Danish register-based population study
Leth-Møller, K., Hansen, A. H., Torstensson, M., Andersen, S. E., Ødum, L., Gislasson, G., Torp-Pedersen, C. T., & Holm, E. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011200 · Cited by 121
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
Changes in pituitary function with ageing and implications for patient care
Veldhuis, J. D. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.38 · Cited by 116
Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults
Mavranezouli, I., Megnin-Viggars, O., Grey, N., Bhutani, G., Leach, J., Daly, C., Dias, S., Welton, N. J., Katona, C., El-Leithy, S., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232245 · Cited by 115
Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis
Farooqi, A., Khunti, K., Abner, S. C., Gillies, C., Morriss, R. K., & Seidu, S. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107816 · Cited by 112
Self-citation
Explanatory factors for the increased mortality of stroke patients with depression
Ayerbe, L., Ayis, S. A., Crichton, S. L., Rudd, A. G., & Wolfe, C. D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000001029 · Cited by 108
Ischaemic Strokes in Patients with Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia: Associations with Iron Deficiency and Platelets
Shovlin, C. L., Chamali, B., Santhirapala, V., Livesey, J. A., Angus, G., Manning, R. A., Laffan, M., MEEK, J. H., Tighe, H. C., & Jackson, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088812 · Cited by 106
Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study
Johnson, C. F., Macdonald, H. J., Atkinson, P., Buchanan, A. I., Downes, N., & Dougall, N. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x658304 · Cited by 105
Antidepressant use and risk of adverse outcomes in people aged 20–64 years: cohort study using a primary care database
Coupland, C. A. C., Hill, T., Morriss, R. K., Moore, M. V., Arthur, A. J., & Hippisley‐Cox, J. (2018) · BMC Medicine · doi:10.1186/s12916-018-1022-x · Cited by 105
Self-citation
Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder – A systematic review and a meta-analysis
Tham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.013 · Cited by 104
Does long term use of psychiatric drugs cause more harm than good?
Gøtzsche, P. C., Young, A. H., & Crace, J. (2015) · BMJ · doi:10.1136/bmj.h2435 · Cited by 109
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence From the CitAD Study
Leonpacher, A. K., Peters, M. E., Drye, L. T., Makino, K. M., Newell, J. A., Devanand, D. P., Frangakis, C., Munro, C. A., Mintzer, J. E., Pollock, B. G., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15020248 · Cited by 104
Comorbidity Profile and Healthcare Utilization in Elderly Patients with Serious Mental Illnesses
Hendrie, H. C., Lindgren, D., Hay, D. P., Lane, K. A., Gao, S., Purnell, C. E., Munger, S., Smith, F. E., Dickens, J., Boustani, M. A., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.056 · Cited by 100
The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis
Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477940 · Cited by 98
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Sobieraj, D. M., Martinez, B. K., Hernández, A. V., Coleman, C. I., Ross, J. S., Berg, K. M., Steffens, D. C., & Baker, W. L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15966 · Cited by 99
Serotonin: a platelet hormone modulating cardiovascular disease
Rieder, M., Gauchel, N., Bode, C., & Duerschmied, D. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02331-0 · Cited by 97
A Social Media Study on the Effects of Psychiatric Medication Use
Saha, K., Sugar, B., Torous, J., Abrahao, B., Kıcıman, E., & De Choudhury, M. (2019) · Proceedings of the International AAAI Conference on Web and Social Media · doi:10.1609/icwsm.v13i01.3242 · Cited by 96
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
Schneider, L. S. S., Frangakis, C., Drye, L. T., Devanand, D. P., Marano, C. M., Mintzer, J., Mulsant, B. H., Munro, C. A., Newell, J. A., Pawluczyk, S., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050648 · Cited by 96
Depression in Cognitive Impairment
Pellegrino, L. D., Peters, M. E., Lyketsos, C. G., & Marano, C. M. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0384-1 · Cited by 101
Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!
Hengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 99
Strategies to reduce use of antidepressants
Kendrick, T. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14475 · Cited by 97
Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database
Hill, T., Coupland, C., Morriss, R., Arthur, A., Moore, M., & Hippisley-Cox, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0701-9 · Cited by 91
Self-citation
Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis
Maund, E., Dewar-Haggart, R., Williams, S., Bowers, H., Geraghty, A. W. A., Leydon, G., May, C., Dawson, S., & Kendrick, T. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.107 · Cited by 90
Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)
de Moura, C. S., Bernatsky, S., Abrahamowicz, M., Παπαϊωάννου, Α., Bessette, L., Adachi, J. D., Goltzman, D., Prior, J. C., Kreiger, N., Towheed, T., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2649-x · Cited by 88
Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis
Shin, D., Oh, Y. H., Eom, C.-S., & Park, S. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7251-9 · Cited by 88
Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study
Martínez, C., Jones, R. W., & Rietbrock, S. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002080 · Cited by 94
Suicide in Stroke Survivors: Epidemiology and Prevention
Pompili, M., Venturini, P., Lamis, D. A., Giordano, G., Serafini, G., Murri, M. B., Amore, M., & Girardi, P. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0233-x · Cited by 87
Treatment of Post-Stroke Depression
STARKSTEIN, S. E., & Hayhow, B. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0570-5 · Cited by 87
Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults ‐ a Swedish nationwide study
Danielsson, B. R. G., Collin, J., Jonasdottir, G., Borg, N., Salmi, P., & Fastbom, J. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12829 · Cited by 89
Prevention of Poststroke Depression: Does Prophylactic Pharmacotherapy Work?
Salter, K. L., Foley, N. C., Zhu, L., Jutai, J. W., & Teasell, R. W. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.03.013 · Cited by 86
Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety
Sultana, J., Spina, E., & Trifirò, G. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1021684 · Cited by 86
Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients
Zhou, Q., Chen, Y., & Zhu, L. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s63756 · Cited by 84
Benzodiazepines and risk of death: Results from two large cohort studies in France and UK
Palmaro, A., Dupouy, J., & Lapeyre‐Mestre, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.006 · Cited by 84
Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry
Bakken, M. S., Engeland, A., Engesæter, L. B., Ranhoff, A. H., Hunskaar, S., & Ruths, S. (2013) · Age and Ageing · doi:10.1093/ageing/aft009 · Cited by 85
Managing antidepressant discontinuation: a systematic review
Maund, E., Stuart, B., Moore, M., Dowrick, C., Geraghty, A. W. A., Dawson, S., & Kendrick, T. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2336 · Cited by 82
Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010
Spindelegger, C. J., Papageorgiou, K., Grohmann, R., Engel, R., Greil, W., Konstantinidis, A., Agelink, M. W., Bleich, S., Ruether, E., Toto, S., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu080 · Cited by 82
COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER WITH AGORAPHOBIA IN OLDER PEOPLE: A COMPARISON WITH YOUNGER PATIENTS
Hendriks, G., Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Voshaar, R. C. O. (2014) · Depression and Anxiety · doi:10.1002/da.22274 · Cited by 82
Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly
van Strien, A. M., Koek, H. L., van Marum, R. J., & Emmelot‐Vonk, M. H. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.01.004 · Cited by 82
Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis
Thorlund, K., Druyts, E., Wu, P., Balijepalli, C., Keohane, D., & Mills, E. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13395 · Cited by 79
Efficacy of pain treatment on mood syndrome in patients with dementia: a randomized clinical trial
Husebo, B. S., Ballard, C. G., Fritze, F., Sandvik, R. K. N. M., & Aarsland, D. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4063 · Cited by 85
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia
Farmand, S., Lindh, J. D., Calissendorff, J., Skov, J., Falhammar, H., Nathanson, D., & Mannheimer, B. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.07.025 · Cited by 77
Acetyl-l-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis
Veronese, N., Stubbs, B., Solmi, M., Ajnakina, O., Carvalho, A. F., & Maggi, S. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000537 · Cited by 77
Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data
Eurelings, L. S. M., van Dalen, J. W., ter Riet, G., van Charante, E. P. M., Richard, E., & van Gool, W. A. (2018) · Clinical Epidemiology · doi:10.2147/clep.s150915 · Cited by 78
Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults
Gandhi, S., Shariff, S. Z., Al‐Jaishi, A. A., Reiss, J. P., Mamdani, M., Hackam, D. G., Li, L., McArthur, E., Weir, M. A., & Garg, A. X. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.08.020 · Cited by 76
The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions
Keszycki, R. M., Fisher, D. W., & Dong, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01109 · Cited by 79
High prevalence of psychotropic drug use among persons with and without Alzheimer׳s disease in Finnish nationwide cohort
Taipale, H. T., Koponen, M., Tanskanen, A. J., Tolppanen, A., Tiihonen, J., & Hartikainen, S. A. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.10.004 · Cited by 73
Depression associated with dementia
Gutzmann, H., & Qazi, A. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0898-8 · Cited by 84
Overview of systematic reviews with meta-analyses on acupuncture in post-stroke cognitive impairment and depression management
Hung, C. Y.-F., Wu, X., Chung, V. C., Tang, E. C.-H., Wu, J. C., & Lau, A. Y. L. (2019) · Integrative Medicine Research · doi:10.1016/j.imr.2019.05.001 · Cited by 71
Microvascular Contribution to Late-Onset Depression: Mechanisms, Current Evidence, Association With Other Brain Diseases, and Therapeutic Perspectives
Empana, J. P., Boutouyrie, P., Lemogne, C., Jouven, X., & van Sloten, T. T. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.012 · Cited by 71
Die Rolle von Placebo- und Nocebomechanismen bei depressiven Erkrankungen und ihrer Therapie
Rief, W. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00940-x · Cited by 70
A comparative study of QT prolongation with serotonin reuptake inhibitors
Ojero-Senard, A., Bénévent, J., Bondon-Guitton, E., Durrieu, G., Chebane, L., Araujo, M., Montastruc, F., & Montastruc, J. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4685-7 · Cited by 58
Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty
Mallery, L. H., MacLeod, T., Allen, M., McLean-Veysey, P., Rodney-Cail, N., Bezanson, E., Steeves, B., LeBlanc, C. H., & Moorhouse, P. A. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1327-4 · Cited by 71
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials
Mead, G. E., Hackett, M. L., Lundström, E., Murray, V., Hankey, G. J., & Dennis, M. S. (2015) · Trials · doi:10.1186/s13063-015-0864-1 · Cited by 68
Interpretation of epidemiologic studies very often lacked adequate consideration of confounding
Hemkens, L. G., Ewald, H., Naudet, F., Ladanie, A., Shaw, J. G., Sajeev, G., & Ioannidis, J. P. A. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.09.013 · Cited by 72
Antidepressant-like effects of paeoniflorin on post-stroke depression in a rat model
Hu, M., Wang, A., Zhao, Z.-Y., Chen, X., Li, Y., & Liu, B. (2019) · Neurological Research · doi:10.1080/01616412.2019.1576361 · Cited by 69
Risk factors for suicidal behaviour in late-life depression: A systematic review
Fernández-Rodrigues, V., Sánchez‐Carro, Y., Lagunas, L. N., Rico‐Uribe, L. A., Pemau, A., Diaz‐Carracedo, P., Díaz‐Marsá, M., Hervás, G., & de la Torre‐Luque, A. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.187 · Cited by 68
Pharmacological treatment of dementia
Schwarz, S. T., Froelich, L., & Burns, A. S. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328358e4f2 · Cited by 69

Authors: Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J.
Affiliations: University of Nottingham (GB)
University of East Anglia (GB)
Corresponding author: Coupland, C.
ORCID: Coupland, C.
Dhiman, P.
Morriss, R.
Arthur, A.
Barton, G.
Venue: BMJ
Publisher: BMJ
Published: 2011-08-02
Volume: 343
Issue: aug02 1
Pages: d4551-d4551
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.d4551
PMC: PMC3149102
OpenAlex: W2044170764
Cited by: 833
References: 66
Citations by year: 2026: 33 · 2025: 44 · 2024: 58 · 2023: 31 · 2022: 51 · 2021: 65 · 2020: 58 · 2019: 76 · 2018: 54 · 2017: 70 · 2016: 72 · 2015: 63 · 2014: 60 · 2013: 44 · 2012: 41
FWCI: 24.08
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: BMJ (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
UEA Digital Repository (University of East Anglia) (submittedVersion)
Funders: National Institute for Health and Care Research (06/42/01)
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords: antidepressants, geriatric depression, adverse drug outcomes, selective serotonin reuptake inhibitors, tricyclic antidepressants, hyponatremia, falls, all-cause mortality, suicide, myocardial infarction, stroke, fracture, gastrointestinal bleeding, epilepsy, traffic accidents, adverse drug reactions, primary care prescribing, older adults, drug safety
MeSH terms: Aged, Aged, 80 and over, Antidepressive Agents, Cause of Death, Depressive Disorder, Drug Administration Schedule, Female, United Kingdom, Humans, Male, Prognosis, Risk Factors, Cohort Studies, Comorbidity, Age Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressant use and risk of adverse outcomes in older people: population based cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks